BRICANYL 0.5mg / ml injectible solution medication leaflet

R03AC03 terbutaline • Respiratory system | Adrenergics, inhalants | Selective beta-2-adrenoreceptor agonists

Terbutaline is a beta-2 adrenergic agonist used for the treatment of bronchial asthma, chronic obstructive bronchitis, and other respiratory conditions involving bronchospasm. It works by relaxing the smooth muscles of the airways, making breathing easier.

The medication is available in the form of tablets, inhalation solutions, or injections and should be used as directed by a doctor. The dosage and frequency of administration are adjusted based on the severity of symptoms.

Patients should be aware of potential side effects, such as tremors, palpitations, or headaches. It is important to inform the doctor of any unusual symptoms or the use of other medications.

Common side effects include tremors, palpitations, nervousness, and headaches. In rare cases, severe reactions such as cardiac arrhythmias or allergic reactions may occur. Patients should be informed of these risks before starting treatment.

General data about BRICANYL 0.5mg / ml

Substance: terbutaline

Date of last drug list: 01-12-2017

Commercial code: W63861001

Concentration: 0.5mg / ml

Pharmaceutical form: injectible solution

Quantity: 10

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: CENEXI SAS - FRANTA

Holder: CN UNIFARM S.A. - ROMANIA

Number: 308/2017/01

Shelf life: 2 years

Pharmaceutical forms available for terbutaline

Concentrations available for terbutaline

0.5mg/ml, 1.5mg/5ml